Company intelligence / Profile preview
Mito BioPharm
Piscataway, New Jersey, United Statesmitobiopharma.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Preclinical
01
Overview
Mito BioPharm is a private biopharmaceutical company focused on developing small molecule therapeutics for metabolic and oncologic diseases. Its pipeline is preclinical and targets NAFLD/NASH, type 2 diabetes, AML, metastatic colon cancer, liver cancer, and T-cell ALL. No clinical results have been reported as all programs remain in the preclinical phase.
- Therapeutic areas
- GastroenterologyOncologyEndocrinology
- Modalities
- Small molecule drug
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
not disclosed
Beyond the preview
Go deeper on Mito BioPharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mito BioPharm.